These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22525566)

  • 1. Biomarkers in obstructive respiratory diseases: an update.
    Braido F; Bagnasco D; Scichilone N; Santus P; Solidoro P; Di Marco F; Corsico A; Canonica GW
    Panminerva Med; 2012 Jun; 54(2):119-27. PubMed ID: 22525566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clara cell 16 protein in COPD sputum: a marker of small airways damage?
    Braido F; Riccio AM; Guerra L; Gamalero C; Zolezzi A; Tarantini F; De Giovanni B; Folli C; Descalzi D; Canonica GW
    Respir Med; 2007 Oct; 101(10):2119-24. PubMed ID: 17624750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory markers for COPD in "susceptible" smokers.
    Tzortzaki EG; Tsoumakidou M; Makris D; Siafakas NM
    Clin Chim Acta; 2006 Feb; 364(1-2):124-38. PubMed ID: 16139829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.
    Antoniu SA
    Biomarkers; 2010 Mar; 15(2):97-103. PubMed ID: 19929747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.
    Garcia-Aymerich J; Gómez FP; Benet M; Farrero E; Basagaña X; Gayete À; Paré C; Freixa X; Ferrer J; Ferrer A; Roca J; Gáldiz JB; Sauleda J; Monsó E; Gea J; Barberà JA; Agustí À; Antó JM;
    Thorax; 2011 May; 66(5):430-7. PubMed ID: 21177668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in the management of COPD.
    Lacoma A; Prat C; Andreo F; Domínguez J
    Eur Respir Rev; 2009 Jun; 18(112):96-104. PubMed ID: 20956129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
    Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
    Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary biomarkers in chronic obstructive pulmonary disease.
    Barnes PJ; Chowdhury B; Kharitonov SA; Magnussen H; Page CP; Postma D; Saetta M
    Am J Respir Crit Care Med; 2006 Jul; 174(1):6-14. PubMed ID: 16556692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD.
    Devanarayan V; Scholand MB; Hoidal J; Leppert MF; Crackower MA; O'Neill GP; Gervais FG
    COPD; 2010 Feb; 7(1):51-8. PubMed ID: 20214463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD.
    Bazeghi N; Gerds TA; Budtz-Jørgensen E; Hove J; Vestbo J
    Respir Med; 2011 Sep; 105(9):1338-44. PubMed ID: 21530214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of exhaled breath condensate pH as a biomarker for COPD.
    MacNee W; Rennard SI; Hunt JF; Edwards LD; Miller BE; Locantore NW; Tal-Singer R
    Respir Med; 2011 Jul; 105(7):1037-45. PubMed ID: 21377342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for biomarkers in chronic obstructive pulmonary disease: current status.
    Nicholas BL
    Curr Opin Pulm Med; 2013 Mar; 19(2):103-8. PubMed ID: 23361193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
    Chen H; Wang D; Bai C; Wang X
    J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases].
    Wu SJ; Chen P; Jiang XN; Liu ZJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.